Wound closure market set to grow in Europe:
This article was originally published in Clinica
The European market for wound closure products is forecast to rise from $814 million in 1999 to $1,172 million by 2006, according to a new report from Frost & Sullivan. European Wound Closure Markets highlights the synthetic absorbable suture and tissue sealant segments as offering the best prospects, with the latter recording market growth of 17.3% in 1999. The tissue sealant market is characterised by a lack of customer loyalty and low levels of customer satisfaction, the report says. For further details: www.frost.com
You may also be interested in...
Scrip’s on-the-ground team in Asia talks about how the regional and wider pharma industry and policymakers have responded so far to the spreading coronavirus outbreak, with a focus on the expedited development of potential drugs and vaccines.
Oncologic Drugs Advisory Committee votes 6-5 that ramucirumab’s benefit/risk profile is favorable in first-line lung cancer, but 13-2 that pivotal trial data do not support approval of Steba’s vascular-targeted, photodynamic therapy for low-risk prostate cancer.